Grants and Contracts Details
Description
Contact PD/PI: Messaoudi Powers, Ilhem
SUMMARY
The developing immune system in the fetus is extremely sensitive to signals from the maternal environment.
Maternal pre-pregnancy (pregravid) obesity has recently emerged as one of the most significant negative
regulators of the offspring’s immune system development and maturation. Findings from animal models indicate
maternal high fat diet-induced obesity is associated with dampened anti-microbial responses and aberrant
inflammatory responses. More importantly, recent epidemiological studies have reported that neonates born to
mothers with high pre-pregnancy BMI are more susceptible to severe infections such as necrotizing enterocolitis
and bacterial sepsis requiring admission to the neonatal intensive care unit (NICU). We have recently shown
that cord blood monocytes from babies born to obese mothers generated dampened immune responses to
lipopolysaccharide (LPS), indicative of a Toll-like receptor (TLR) signaling defect. These observations provide a
potential explanation for the increased susceptibility to severe infections in neonates born to obese mothers.
However, the mechanisms underlying reduced host defense in offspring of obese mothers remain poorly
understood. The goal of this application is to address this knowledge gap. Specically, we will define functional
alterations in human neonatal monocytes induced by maternal pre-pregnancy obesity and uncover their
molecular underpinnings. Moreover, we will link data from our experiments with clinical parameters collected
from the pregnant mother as well as the child at birth and during the first year of life. The novelty of this application
lies in the systems biology approach that integrates genomic and functional readouts with clinical metadata.
Completion of the proposed experiments will reveal the molecular mechanisms that result in altered neonatal
monocyte function and our findings will form a basis for developing early interventions.
Page 6
Project Summary/Abstract
Status | Finished |
---|---|
Effective start/end date | 11/1/21 → 8/31/22 |
Funding
- National Institute of Allergy and Infectious Diseases: $218,251.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.